Early Phase 1 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For all participants:
- The person is able to understand what the study involves and agrees to take part in writing.
- The person is able to follow the study schedule and complete all required assessments.
For healthy participants (certain parts of the trial):
- Adults (male or female) aged 18 to 65 years at the time of screening.
- People with a body mass index (a measure of body weight relative to height) between 18 and 32, and a body weight between 50 kg and 120 kg.
- People who smoke fewer than 10 nicotine-containing products per month, and who have not used any tobacco or nicotine products (including quit-smoking aids) for at least 2 weeks before the first dose, confirmed by a negative nicotine test.
- People who are generally in good health, with kidney-related test results within an acceptable range and no significant health concerns identified during screening, as assessed by the lead doctor.
For participants with a history of a heart condition (another part of the trial):
- Adults (male or female) aged 40 to 79 years, who have been diagnosed with acute coronary syndrome (a serious heart condition involving reduced blood flow to the heart), at least 12 months after the event occurred.
- People with a body mass index of 18 or above.
- People who are medically stable with no significant health concerns found during screening, as assessed by the lead doctor.
- People who have been on a steady, unchanged treatment plan for their heart condition — including medicines such as statins, blood thinners, or anti-clotting medications — for at least 3 months before screening, with no planned changes to that treatment during the study.
Who may not be able to join:
- No formal exclusion criteria were listed in the information provided. (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (707) 200-3610
Australian sites
+61(08)70887900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Safety outcome measures (Adverse Events); Safety outcome measures (Vital Signs: Systolic Blood Pressure); Safety outcome measures (Vital Signs: Diastolic Blood Pressure); Safety outcome measures (Vital signs: Heart Rate); Safety outcome measures (Vital signs: Respiratory Rate); Safety outcome measures (Vital signs: Temperature); Safety outcome measures (Clinical Laboratory Parameters); Safety outcome measures (ECG QTCF Interval); Safety outcome measures (Injection site reactions); Safety outcome measures (Audiometry: PTA); Safety outcome measures (Audiometry: HFA); Safety outcome measures (Aud...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.